High-dose chemotherapy and autologous SCT (auto-SCT) have become a standard of care for many patients with hematological malignancies, in particular chronic lymphoproliferative disorders. 1, 2, 3 ...
Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022 Effective diagnosis, prognostication, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results